𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zuclopenthixol decanoate in schizophrenia: Serum levels and clinical state

✍ Scribed by A. Jørgensen; T. Aaes-Jørgensen; A. Gravem; K. F. Amthor; S. J. Dencker; I. Rosell; P. C. Baastrup; J. Buckhave; L. F. Gram

Publisher
Springer
Year
1985
Tongue
English
Weight
405 KB
Volume
87
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zuclopenthixol levels in serum and breas
Zuclopenthixol levels in serum and breast milk
✍ Tove Aaes-Jørgensen; Flemming Bjørndal; Ulla Bartels 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 155 KB

Breast milk and serum samples were obtained from six psychotic patients 3 days-10 months after delivery. Five of the women were given zuclopenthixol PO daily, and one was given zuclopenthixol decanoate IM every 2 weeks. Zuclopenthixol was estimated in breast milk and serum by high performance liquid

Serum concentrations and clinical effect
Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo®
✍ A. Amdisen; T. Aaes-Jørgensen; N. J. Thomsen; V. T. Madsen; M. S. Nielsen 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 495 KB

Zuclopenthixol acetate, 5%, in Viscoleo® was administered IM to 19 acutely disturbed, psychotic patients in doses of 50-150 mg. Fifteen patients received one injection, whereas four of the patients had two or three injections, usually with intervals of 3 days. The zuclopenthixol concentrations in se

Relations of clinical features, subgroup
Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia
✍ Robert D. Oades; Ansgard Klimke; Uwe Henning; Marie Luise Rao 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Background: Plasma and serum indices of monoaminergic activity reflect partly the illness of schizophrenia (e.g. hva/deficit syndrome) and sometimes the symptoms (e.g. hva/anhedonia). but, such studies have rarely taken both metabolites and parent amines or inter-amine activity ratios into accou

Serum hepatocyte growth factor levels in
Serum hepatocyte growth factor levels in liver diseases: Clinical implications
✍ Goshi Shiota; Jun-Ichi Okano; Hironaka Kawasaki; Tomokazu Kawamoto; Toshikazu Na 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

## Clinical Implications GOSHI SHIOTA,' JUN-ICHI OKANO,' HIRONAKA KAWASAKI,' TOMOKAZU KAWAMOTO,' AND TOSHIKAZU NAKA1LIURA3 Although recent studies have shown that hepatocyte growth factor (HGF) is a potent mitogen in uiuo, the significance of serum HGF in liver diseases remains unclear. To clarif

Comparison of serum levels after intramu
Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo®to schizophrenic patients
✍ J. A. Stauning; L. Kirk; A. Jørgensen 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 365 KB

The serum concentrations of cis(Z)-flupentixol after injection of 2 % and 10 % cis(Z)-flupentixol decanoate in Viscoleo ~ (Depixol '~ injection, Fluanxob ~: Depot) have been investigated in a crossover study with eight schizophrenic patients. No statistically significant difference was found between